Pharmaceuticals

mRNA Therapeutics Market Growth Outlook 2026–2030 with Innovation Trends and Competitive Analysis

March 23, 2026March 23, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The mRNA Therapeutics Market Across 2026–2030?

The mrna therapeutics market size has experienced consistent expansion in recent years. This market is projected to expand from $35.9 billion in 2025 to $37.18 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 3.6%. Historically, this growth has been driven by factors such as the significant success of mrna vaccines in combating infectious diseases, advancements in nucleic acid delivery technologies, a deeper comprehension of gene expression control, early research confirming mrna-based protein synthesis, and substantial public funding for mrna research platforms.

The mrna therapeutics market size is projected for consistent expansion over the upcoming years. It is anticipated to reach $42.32 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 3.3%. This growth during the forecast timeframe is attributable to several factors: an increasing demand for targeted and personalized treatments, the broadening of mrna applications within oncology and rare disease fields, escalating biopharmaceutical investments in mrna pipelines, a growing count of mrna drugs progressing into clinical trials, and critical alliances formed between biotech companies and research bodies. Key trends anticipated for this period encompass the diversification of mrna therapeutics beyond vaccines, an intensified focus on protein replacement therapies leveraging mrna, an expanding clinical pipeline for non-vaccine mrna drugs, heightened investment in lipid nanoparticle delivery systems, and the swift development of comprehensive mrna manufacturing capabilities.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17205&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The mRNA Therapeutics Market?

The increasing incidence of long-lasting and communicable diseases is anticipated to propel the expansion of the mRNA therapeutics market. These enduring and transmissible diseases, such as tuberculosis, HIV/AIDS, and hepatitis, are conditions that persist for extended periods and are capable of spreading between individuals. The rise in these diseases stems from factors like increased global mobility and deficiencies in healthcare infrastructure, which contribute to higher transmission rates and hinder effective disease management. mRNA therapeutics support enhanced disease control by rapidly enabling the body to produce proteins that boost immune responses, thereby facilitating the accelerated development of targeted vaccines and treatments. For instance, in March 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Therefore, the growing prevalence of long-lasting and communicable diseases is a key factor driving the growth of the mRNA therapeutics market.

What Segmentation Levels Are Considered In The mRNA Therapeutics Market?

The mrna therapeutics market covered in this report is segmented –

1) By Product: Vaccines, Drugs

2) By Application: Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications

3) By End Use: Hospitals And Clinics, Research Organizations, Other End Uses

Subsegments:

1) By Vaccines: Infectious Disease Vaccines, Cancer Vaccines, Other Therapeutic Vaccines

2) By Drugs: Oncology Drugs, Cardiovascular Drugs, Autoimmune Disease Drugs, Other mRNA-Based Drugs

What Trends Are Projected To Affect The mRNA Therapeutics Market?

Leading firms within the mRNA therapeutics market are concentrating on creating novel approaches, including personalized neoantigen vaccines, to boost immune reactions and better survival rates for cancer sufferers. These individualized neoantigen vaccines represent cancer treatments tailored to each patient, utilizing distinct mutations found in their tumors to prompt the immune system to identify and eliminate malignant cells. For instance, in July 2023, Merck & Co., Inc., a US-based research-intensive biopharmaceutical company, partnered with Moderna Therapeutics, Inc., a US-based biotechnology company, to initiate a Phase 3 randomized clinical trial (V940-001) to evaluate mRNA-4157 (V940) in combination with KEYTRUDA® (pembrolizumab) as an adjuvant treatment for patients with resected high-risk (Stage IIB-IV) melanoma. This current investigation builds upon encouraging findings from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial, which demonstrated a significant advantage of the combination therapy compared to KEYTRUDA used by itself in lowering the likelihood of recurrence and the spread of metastasis. The objective of the Phase 3 trial is to validate these earlier observations by measuring relapse-free survival and distant metastasis-free survival, designated as its primary and secondary endpoints, respectively.

Which Leading Firms Are Contributing To The Growth Of The mRNA Therapeutics Market?

Major companies operating in the mrna therapeutics market are Pfizer Inc., Novartis AG, Sanofi AG, AstraZeneca plc, GlaxoSmithKline plc, Hoffmann-La Roche AG, Moderna Therapeutics Inc, BioNTech SE, Vertex Pharmaceuticals Incorporated, Catalent Inc, Alnylam Pharmaceuticals Inc, Sarepta Therapeutics Inc, Arcturus Therapeutics Holdings Inc, CureVac N.V, Ethris GMBH, eTheRNA immunotherapies NV, In-Cell-Art S.A.S., Nutcracker Therapeutics Inc, SCM LifeScience Co Ltd, Suzhou Abogen Biosciences Co Ltd, Tiba Biotech LLC, CSPC Pharmaceutical Group, CRISPR Therapeutics AG

Read the full mrna therapeutics market report here:

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

Which Regions Are Projected To Dominate The mRNA Therapeutics Market In The Coming Years?

North America was the largest region in the mRNA therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mrna therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored mRNA Therapeutics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17205&type=smp

Browse Through More Reports Similar to the Global mRNA Therapeutics Market 2026, By The Business Research Company

Mrna Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report

Ribose Nucleic Acid Rna Based Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/ribose-nucleic-acid-rna-based-therapeutics-global-market-report

Rna Targeting Small Molecules Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecules-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795